Company Summary

Women’s reproductive self-care in the Information Age
FDA-cleared first application means early revenues, profitability
Transformational technology platform will empower women & enable physicians to better manage women's health from adolescence to menopause
The first app helps women to either conceive or to avoid pregnancy without drugs, hormones or surgery
Important applications will follow
See prototype-era video & slides at wp.me/a9ivm-1f0

Team

Vaclav Kirsner

Founder CEO

Founding CEO of bioZhena Corporation, as the developer of tissue-biosensing of folliculogenesis in vivo. He was a Senior Research Scientist at the pharmaceutical firm of WRL of Glaxo Wellcome (UK), specialized in exploratory research and interdisciplinary applications. He earned his PhD in physical chemistry-electrochemistry from the University of Southampton, UK and his Masters degree from Charles University in Prague. Pls email to schedule call